Stéphanie Durand

Biophysical properties of the clinical-stage antibody landscape

Tushar Jain, Tingwan Sun, Stéphanie Durand et al. · Proceedings of the National Academy of Sciences · 2017 · 600 citations · Full text

Immunocytochemical Technique, Engineering, Immunology +18

APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells

Grégory Berger, Stéphanie Durand, Guillaume Fargier et al. · PLoS Pathogens · 2011 · 193 citations · Full text

Specific Inhibitor, Viral Replication, Immunology +19

IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity

Kévin Tartour, Romain Appourchaux, Julien Burlaud‐Gaillard et al. · Retrovirology · 2014 · 132 citations · Full text

A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1–derived lentiviral vectors

G Berger, Stéphanie Durand, Caroline Goujon et al. · Nature Protocols · 2011 · 96 citations

Efficient Method, Hiv-1–derived Lentiviral Vectors, Medicine +10

Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells

Flaria El Khoury, Laurent Corcos, Stéphanie Durand et al. · International Journal of Oncology · 2016 · 68 citations

Stem Cell Compartment, Oncology, Cancer Stemness +14